| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.122.039 |
| Chemical and physical data | |
| Formula | C13H12N2O2 |
| Molar mass | 228.251 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ozagrel (INN) is anantiplatelet agent working as athromboxane A2 synthesis inhibitor.[1]
Thefree-radical halogenation of ethyl 4-methylcinnamate (1) withN-bromosuccinimide in the presence ofbenzoyl peroxide gives ethyl 4-bromomethylcinnamate (2).[2]Alkylation ofimidazole (3) with this material gives the ethyl ester (4) of the drug, which issaponified to give ozagrel.[3][4]
Thisdrug article relating to theblood andblood forming organs is astub. You can help Wikipedia byexpanding it. |